Exobiosphere
Founded 2024 · 27 employees on LinkedIn · 2 known investors
Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.
Founders & leadership
Exobiosphere was founded in 2024 by Kyle Acierno, Bruno Santos, and Olivia Borgue.
Investors · 2
In the news
Frequently asked questions
- What does Exobiosphere do?
- Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.
- Who founded Exobiosphere?
- Exobiosphere was founded by Kyle Acierno, Bruno Santos, Olivia Borgue in 2024.
- Who are Exobiosphere's investors?
- Exobiosphere's investors include Expansion Ventures, Expon Capital.